Kochav Defense Acquisition Corp.

Print
General Information
Business:

(Incorporated in the Cayman Islands)

We are a newly organized blank check company. We intend to focus on acquiring a business in the defense and aerospace industries.

Menachem Shalom has been our CEO since inception. Since September 2024, he has been the CEO and a director of Nukkleus (NASDAQ: NUKK), a public company focused on innovative acquisition companies specializing in identifying, acquiring, and transforming high-potential businesses across key sectors, including defense, financial services, real estate, industrial and technology. 

Asaf Yarkoni has been our CFO since April 2025. Since 2021, he has been the CFO of Kamari Pharma Ltd., a biotech startup company developing drugs for rare genetic skin diseases. Also since 2021, he has been the CFO of Aroma Republic Ltd., a high-tech startup company developing home tech fragrances, based on data-driven technology to create a customized scent product.

(Note: Kochav Defense Acquisition Corp. filed its S-1 on April 25, 2025, and disclosed the terms for its SPAC IPO: 22.0 million units at $10.00 each to raise $220.0 million. Each unit consists of one Class A ordinary share and one right to receive one-seventh (1/7th) of a share upon the consummation of an initial business combination.)
Industry: BLANK CHECKS
Employees: 0
Founded: 2024
Contact Information
Address 575 Fifth Avenue 14th Floor New York, NY 10017 (646) 257-4214
Phone Number (646) 257-4214
Web Address
View Prospectus: Kochav Defense Acquisition Corp.
Financial Information
Market Cap $224.8mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol KOXXU
Exchange NASDAQ
Shares (millions): 22.0
Price range $10.00 - $10.00
Est. $ Volume $220.0 mil
Manager / Joint Managers SPAC Advisory Partners (A Division of Kingswood Capital Partners)
CO-Managers
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change